News

David J. Schlanger, Executive Chairman and Director of Progyny, Inc. (NASDAQ:PGNY), filed a Form 4 on November 9, 2026, disclosing the exercise of stock options and subsequent sale of a combined 164,608 shares of common stock across two transaction dates, November 5 and November …

Eric Friedrichsen, Chief Executive Officer and Director of CS Disco, Inc., filed a Form 4 on November 9, 2026, disclosing a purchase of CS Disco common stock on November 6, 2026.

Peter Anevski, Chief Executive Officer and Director of Progyny, Inc., filed a Form 4 on November 9, 2026, disclosing option exercises and common stock sales on November 5 and November 9, 2026, pursuant to a Rule 10b5-1 trading plan.

Modular Medical, Inc. Chief Operating Officer Kevin Schmid filed a Form 4 on November 9, 2026, disclosing the acquisition of a stock option to purchase 100,000 shares of common stock at an exercise price of $1.72, with a transaction date of October 29, 2026.

Modular Medical, Inc. director and officer Paul DiPerna filed a Form 4 on November 9, 2026, disclosing the acquisition of an option to purchase 150,000 shares of common stock on October 29, 2026.

Director Michael George Walsh filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,300 ordinary shares of AerCap Holdings N.V. on the NYSE.

Summit Investors GE IX/VC IV (UK), L.P. filed a Form 144 notice with the SEC on November 9, 2026, disclosing a proposed sale of 2,016 shares of Klaviyo, Inc. Series A common stock on the NYSE.